Cefoxitin Sodium API - Global ﾂ鮓ｹﾔｭｴｴ Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510246757

Publication Date:

October 11, 2024

Pages:

125

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Cefoxitin Sodium is a semisynthetic cephamycin antibiotic resistant to beta-lactamase. It is derived from Cephamycin C and is highly resistance to ﾎｲ-lactamase inactivation. Also an antibacterial, cefoxitin sodium acts by adhering to bacterial penicillin-binding proteins, thereby inhibiting cell wall synthesis.
The global market for Cefoxitin Sodium API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cefoxitin Sodium API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cefoxitin Sodium API by region & country, by Type, and by Application.
The Cefoxitin Sodium API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cefoxitin Sodium API.
ﾂ鮓ｹﾔｭｴｴ Segmentation
By Company
Orchid Pharma
ACS DOBFAR SPA
Aurobindo Pharma Limited
ABL Brasil
Kaliberr Labs
Fresenius Kabi Anti-Infectives
Grand Health Industrial
Clearsynth
TargetMol Chemicals
Toronto Research Chemicals
Tosun Pharmaceutical
Apeloa Pharmaceutical
Segment by Type:
Purity 竕･ 98 %
Purity 竕･ 99 %
Segment by Application
Research Institute
Pharmaceutical
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cefoxitin Sodium API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cefoxitin Sodium API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cefoxitin Sodium API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 ﾂ鮓ｹﾔｭｴｴ Overview
1.1 Cefoxitin Sodium API Product Introduction
1.2 Global Cefoxitin Sodium API ﾂ鮓ｹﾔｭｴｴ Size Forecast
1.2.1 Global Cefoxitin Sodium API Sales Value (2019-2030)
1.2.2 Global Cefoxitin Sodium API Sales Volume (2019-2030)
1.2.3 Global Cefoxitin Sodium API Sales Price (2019-2030)
1.3 Cefoxitin Sodium API ﾂ鮓ｹﾔｭｴｴ Trends & Drivers
1.3.1 Cefoxitin Sodium API Industry Trends
1.3.2 Cefoxitin Sodium API ﾂ鮓ｹﾔｭｴｴ Drivers & Opportunity
1.3.3 Cefoxitin Sodium API ﾂ鮓ｹﾔｭｴｴ Challenges
1.3.4 Cefoxitin Sodium API ﾂ鮓ｹﾔｭｴｴ Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cefoxitin Sodium API Players Revenue Ranking (2023)
2.2 Global Cefoxitin Sodium API Revenue by Company (2019-2024)
2.3 Global Cefoxitin Sodium API Players Sales Volume Ranking (2023)
2.4 Global Cefoxitin Sodium API Sales Volume by Company Players (2019-2024)
2.5 Global Cefoxitin Sodium API Average Price by Company (2019-2024)
2.6 Key Manufacturers Cefoxitin Sodium API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Cefoxitin Sodium API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cefoxitin Sodium API
2.9 Cefoxitin Sodium API ﾂ鮓ｹﾔｭｴｴ Competitive Analysis
2.9.1 Cefoxitin Sodium API ﾂ鮓ｹﾔｭｴｴ Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Cefoxitin Sodium API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cefoxitin Sodium API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity 竕･ 98 %
3.1.2 Purity 竕･ 99 %
3.2 Global Cefoxitin Sodium API Sales Value by Type
3.2.1 Global Cefoxitin Sodium API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cefoxitin Sodium API Sales Value, by Type (2019-2030)
3.2.3 Global Cefoxitin Sodium API Sales Value, by Type (%) (2019-2030)
3.3 Global Cefoxitin Sodium API Sales Volume by Type
3.3.1 Global Cefoxitin Sodium API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Cefoxitin Sodium API Sales Volume, by Type (2019-2030)
3.3.3 Global Cefoxitin Sodium API Sales Volume, by Type (%) (2019-2030)
3.4 Global Cefoxitin Sodium API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Institute
4.1.2 Pharmaceutical
4.1.3 Others
4.2 Global Cefoxitin Sodium API Sales Value by Application
4.2.1 Global Cefoxitin Sodium API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cefoxitin Sodium API Sales Value, by Application (2019-2030)
4.2.3 Global Cefoxitin Sodium API Sales Value, by Application (%) (2019-2030)
4.3 Global Cefoxitin Sodium API Sales Volume by Application
4.3.1 Global Cefoxitin Sodium API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Cefoxitin Sodium API Sales Volume, by Application (2019-2030)
4.3.3 Global Cefoxitin Sodium API Sales Volume, by Application (%) (2019-2030)
4.4 Global Cefoxitin Sodium API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Cefoxitin Sodium API Sales Value by Region
5.1.1 Global Cefoxitin Sodium API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cefoxitin Sodium API Sales Value by Region (2019-2024)
5.1.3 Global Cefoxitin Sodium API Sales Value by Region (2025-2030)
5.1.4 Global Cefoxitin Sodium API Sales Value by Region (%), (2019-2030)
5.2 Global Cefoxitin Sodium API Sales Volume by Region
5.2.1 Global Cefoxitin Sodium API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Cefoxitin Sodium API Sales Volume by Region (2019-2024)
5.2.3 Global Cefoxitin Sodium API Sales Volume by Region (2025-2030)
5.2.4 Global Cefoxitin Sodium API Sales Volume by Region (%), (2019-2030)
5.3 Global Cefoxitin Sodium API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Cefoxitin Sodium API Sales Value, 2019-2030
5.4.2 North America Cefoxitin Sodium API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Cefoxitin Sodium API Sales Value, 2019-2030
5.5.2 Europe Cefoxitin Sodium API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Cefoxitin Sodium API Sales Value, 2019-2030
5.6.2 Asia Pacific Cefoxitin Sodium API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Cefoxitin Sodium API Sales Value, 2019-2030
5.7.2 South America Cefoxitin Sodium API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cefoxitin Sodium API Sales Value, 2019-2030
5.8.2 Middle East & Africa Cefoxitin Sodium API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cefoxitin Sodium API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cefoxitin Sodium API Sales Value
6.2.1 Key Countries/Regions Cefoxitin Sodium API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Cefoxitin Sodium API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Cefoxitin Sodium API Sales Value, 2019-2030
6.3.2 United States Cefoxitin Sodium API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cefoxitin Sodium API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cefoxitin Sodium API Sales Value, 2019-2030
6.4.2 Europe Cefoxitin Sodium API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cefoxitin Sodium API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cefoxitin Sodium API Sales Value, 2019-2030
6.5.2 China Cefoxitin Sodium API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cefoxitin Sodium API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cefoxitin Sodium API Sales Value, 2019-2030
6.6.2 Japan Cefoxitin Sodium API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cefoxitin Sodium API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cefoxitin Sodium API Sales Value, 2019-2030
6.7.2 South Korea Cefoxitin Sodium API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cefoxitin Sodium API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cefoxitin Sodium API Sales Value, 2019-2030
6.8.2 Southeast Asia Cefoxitin Sodium API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cefoxitin Sodium API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cefoxitin Sodium API Sales Value, 2019-2030
6.9.2 India Cefoxitin Sodium API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cefoxitin Sodium API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Orchid Pharma
7.1.1 Orchid Pharma Company Information
7.1.2 Orchid Pharma Introduction and Business Overview
7.1.3 Orchid Pharma Cefoxitin Sodium API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Orchid Pharma Cefoxitin Sodium API Product Offerings
7.1.5 Orchid Pharma Recent Development
7.2 ACS DOBFAR SPA
7.2.1 ACS DOBFAR SPA Company Information
7.2.2 ACS DOBFAR SPA Introduction and Business Overview
7.2.3 ACS DOBFAR SPA Cefoxitin Sodium API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 ACS DOBFAR SPA Cefoxitin Sodium API Product Offerings
7.2.5 ACS DOBFAR SPA Recent Development
7.3 Aurobindo Pharma Limited
7.3.1 Aurobindo Pharma Limited Company Information
7.3.2 Aurobindo Pharma Limited Introduction and Business Overview
7.3.3 Aurobindo Pharma Limited Cefoxitin Sodium API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Aurobindo Pharma Limited Cefoxitin Sodium API Product Offerings
7.3.5 Aurobindo Pharma Limited Recent Development
7.4 ABL Brasil
7.4.1 ABL Brasil Company Information
7.4.2 ABL Brasil Introduction and Business Overview
7.4.3 ABL Brasil Cefoxitin Sodium API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 ABL Brasil Cefoxitin Sodium API Product Offerings
7.4.5 ABL Brasil Recent Development
7.5 Kaliberr Labs
7.5.1 Kaliberr Labs Company Information
7.5.2 Kaliberr Labs Introduction and Business Overview
7.5.3 Kaliberr Labs Cefoxitin Sodium API Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Kaliberr Labs Cefoxitin Sodium API Product Offerings
7.5.5 Kaliberr Labs Recent Development
7.6 Fresenius Kabi Anti-Infectives
7.6.1 Fresenius Kabi Anti-Infectives Company Information
7.6.2 Fresenius Kabi Anti-Infectives Introduction and Business Overview
7.6.3 Fresenius Kabi Anti-Infectives Cefoxitin Sodium API Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Fresenius Kabi Anti-Infectives Cefoxitin Sodium API Product Offerings
7.6.5 Fresenius Kabi Anti-Infectives Recent Development
7.7 Grand Health Industrial
7.7.1 Grand Health Industrial Company Information
7.7.2 Grand Health Industrial Introduction and Business Overview
7.7.3 Grand Health Industrial Cefoxitin Sodium API Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Grand Health Industrial Cefoxitin Sodium API Product Offerings
7.7.5 Grand Health Industrial Recent Development
7.8 Clearsynth
7.8.1 Clearsynth Company Information
7.8.2 Clearsynth Introduction and Business Overview
7.8.3 Clearsynth Cefoxitin Sodium API Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Clearsynth Cefoxitin Sodium API Product Offerings
7.8.5 Clearsynth Recent Development
7.9 TargetMol Chemicals
7.9.1 TargetMol Chemicals Company Information
7.9.2 TargetMol Chemicals Introduction and Business Overview
7.9.3 TargetMol Chemicals Cefoxitin Sodium API Sales, Revenue and Gross Margin (2019-2024)
7.9.4 TargetMol Chemicals Cefoxitin Sodium API Product Offerings
7.9.5 TargetMol Chemicals Recent Development
7.10 Toronto Research Chemicals
7.10.1 Toronto Research Chemicals Company Information
7.10.2 Toronto Research Chemicals Introduction and Business Overview
7.10.3 Toronto Research Chemicals Cefoxitin Sodium API Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Toronto Research Chemicals Cefoxitin Sodium API Product Offerings
7.10.5 Toronto Research Chemicals Recent Development
7.11 Tosun Pharmaceutical
7.11.1 Tosun Pharmaceutical Company Information
7.11.2 Tosun Pharmaceutical Introduction and Business Overview
7.11.3 Tosun Pharmaceutical Cefoxitin Sodium API Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Tosun Pharmaceutical Cefoxitin Sodium API Product Offerings
7.11.5 Tosun Pharmaceutical Recent Development
7.12 Apeloa Pharmaceutical
7.12.1 Apeloa Pharmaceutical Company Information
7.12.2 Apeloa Pharmaceutical Introduction and Business Overview
7.12.3 Apeloa Pharmaceutical Cefoxitin Sodium API Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Apeloa Pharmaceutical Cefoxitin Sodium API Product Offerings
7.12.5 Apeloa Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Cefoxitin Sodium API Industrial Chain
8.2 Cefoxitin Sodium API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cefoxitin Sodium API Sales Model
8.5.2 Sales Channel
8.5.3 Cefoxitin Sodium API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Orchid Pharma
ACS DOBFAR SPA
Aurobindo Pharma Limited
ABL Brasil
Kaliberr Labs
Fresenius Kabi Anti-Infectives
Grand Health Industrial
Clearsynth
TargetMol Chemicals
Toronto Research Chemicals
Tosun Pharmaceutical
Apeloa Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

ﾌ�

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

ﾌ�

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.